P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 25 April 2015 | 8:45 am

Miles White Recaps Abbott's 2014 Chairman and Chief Executive Officer Miles D. White highlights a year of strong performance at the company's Annual Shareholders Meeting.

Miles White Recaps Abbott's 2014: A Year of Strong Performance, Strategic Actions more ...

Published 25 April 2015 | 8:27 am

Malaria vaccine candidate has demonstrated efficacy over 3-4 years of follow-up

Final results from Phase III trial suggest substantial public health benefits could be provided by the RTS,S malaria vaccine candidate in endemic regions in sub-Saharan Africa more ...

Published 25 April 2015 | 7:24 am

Gilead Announces Results From Studies Evaluating Sofosbuvir-Based Regimens in Chronic Hepatitis C Patients With Genotypes 2-5

-- High Cure Rates Observed Across a Range of Genotypes -- more ...

Published 24 April 2015 | 11:04 pm

Lilly's CYRAMZA® (ramucirumab) Receives Fourth FDA Approval

CYRAMZA Now Approved in the U.S. for Use with FOLFIRI in Second-Line Treatment of Metastatic Colorectal Cancer more ...

Published 24 April 2015 | 12:53 pm

New Chevrolet concept car draped in dazzling color from BASF

New Chevrolet-FNR concept car unveils at Auto Shanghai 2015 more ...

Published 24 April 2015 | 8:12 am

AstraZeneca PLC first quarter results 2015

Pascal Soriot, Chief Executive Officer, commenting on the results, said: more ...

Published 24 April 2015 | 7:10 am

AstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-oncology

AstraZeneca and MedImmune, the Company's global biologics research and development arm, today announced that they have entered into a collaboration to accelerate and more ...

Published 24 April 2015 | 7:10 am

AstraZeneca enters strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor programme for patients with serious blood cancers

AstraZeneca and MedImmune, the Company's global biologics research and development arm, today announced that they have entered into an exclusive collaboration more ...

Published 23 April 2015 | 11:33 pm

Press Releases

Home / News / Press Releases / Gilead Sciences to Release First Quarter 2015 Financial Results on Thursday, April 30, 2015 more ...

Published 23 April 2015 | 8:23 pm

Pfizer Hosts Annual Meeting Of Shareholders

Thursday, April 23, 2015 - 2:07pm EDT The board of directors of Pfizer Inc. today declared a 28-cent second-quarter 2015 dividend on the company's common stock, payable more ...

Pharma Documentation Ring:
24 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Sept 22-25, 2015 – Zuerich/Switzerland

Next Annual General Meeting, Sept 22-25, 2015 – Zuerich/Switzerland

Foto: © MadGeographer